What Is Foundayo (Orforglipron)? A Clear Guide for GLP-1 Users

Foundayo is the brand name for orforglipron from Eli Lilly. It is a non-peptide, small-molecule GLP-1 medicine taken once daily as a pill. It was FDA approved on April 1, 2026, and launched on April 6, 2026. This matters because it is designed as an oral option that is not an injection.

Foundayo is taken once daily and can be taken any time of day. Unlike some other GLP-1 pills, it has no fasting or water restrictions. That can make it simpler for people who struggle with a strict “empty stomach” routine. Your prescribing clinician should confirm how to take it based on your full medication list and schedule.

As of June 12, 2026, another GLP-1 pill people discuss is the Wegovy pill (oral semaglutide 25 mg), which launched in January 2026 after FDA approval in December 2025. The Wegovy pill must be taken first thing in the morning with a small sip of water, at least 30 minutes before food, drinks, or other oral medicines. Foundayo does not have those fasting and timing rules. If you are choosing between options, ask your prescriber which routine is realistic for you day to day.

Foundayo is available through LillyDirect, telehealth, and retail pharmacies. That gives you a few paths depending on whether you already have a clinician, use virtual care, or prefer your local pharmacy. Before your visit, confirm which pharmacies in your area can order it and what documentation they need. If you have insurance, ask your plan what coverage rules apply and whether prior authorization is required.

At launch, Foundayo self-pay started at $149 per month for the lowest dose, and a commercial savings card could be as low as $25 per month for eligible patients. These programs can change, and eligibility rules can be specific. At the time of writing, you should confirm current pricing and savings details directly with Eli Lilly or your pharmacist. If a price sounds too good to be true from an unofficial seller, pause and verify through the manufacturer channel.

GLP-1 medicines are generally not recommended during pregnancy, and questions about breastfeeding, fertility, contraception, or hormone therapy should go to your prescriber or OB-GYN. If you use tirzepatide products (like Mounjaro or Zepbound), know that tirzepatide can reduce oral contraceptive absorption around starts and dose increases—ask your clinician what that means for you. Do not change, stop, or mix GLP-1 medicines without your prescribing provider’s guidance. If you take other oral medicines, a pharmacist can help you plan timing and reduce confusion.